<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://blog.lifesciencenation.com/2026/04/14/biometas-and-zshk-laboratories-announce-strategic-integration-to-build-a-full-preclinical-cro-platform/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-14T15:22:21+00:00</news:publication_date><news:title>BioMetas and ZSHK Laboratories Announce Strategic Integration to Build a Full Preclinical CRO Platform</news:title><news:keywords>venture capital, Healthcare, news, science, technology, startups, marketing, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence, digital-marketing, chatgpt</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/04/14/kobe-biomedical-innovation-cluster-title-sponsor-of-resi-san-diego-2026-to-host-japan-life-science-showcase/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-14T13:47:07+00:00</news:publication_date><news:title>Kobe Biomedical Innovation Cluster, Title Sponsor of RESI San Diego 2026, to Host Japan Life Science Showcase</news:title><news:keywords>venture capital, Healthcare, news, technology, startups, health, travel, AI, business, entrepreneurship, food, finance, investing, books</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/04/14/from-proof-to-approval-regulatory-risk/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-14T13:47:05+00:00</news:publication_date><news:title>From Proof to Approval: Regulatory Risk </news:title><news:keywords>venture capital, Healthcare, news, science, technology, startups, marketing, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence, digital-marketing, chatgpt</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/04/14/innovators-pitch-challenge-winner-spotlight-bram-de-moor-of-you2yourself/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-14T13:47:02+00:00</news:publication_date><news:title>Innovator’s Pitch Challenge Winner Spotlight: Bram De Moor of You2Yourself </news:title><news:keywords>news, science, technology, mental health, health, travel, AI, business, hotels, food, restaurants, artificial-intelligence, art, writing, books, nutrition, digital-marketing, poetry, fitness, cooking, recipes, beauty, wellness, photography, lifestyle, weight-loss, exercise, makeup, inspiration</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/04/14/the-needle-issue-25/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-14T13:12:03+00:00</news:publication_date><news:title>The Needle Issue #25</news:title><news:keywords>science, technology, mental health, health, AI, business, food, finance, investing, cancer, biology, immune-system, genetics, artificial-intelligence, art, writing, books, nutrition, alzheimers, poetry, painting, fitness, beauty, reading, immunotherapy, wellness, fiction, book-review, huntingtons-disease, literature</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/04/14/hot-investor-mandate-europe-based-life-science-focused-investment-firm-seeks-early-stage-biotech-companies-with-strong-preclinical-data/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-14T11:20:00+00:00</news:publication_date><news:title>Hot Investor Mandate: Europe-Based Life Science-Focused Investment Firm Seeks Early-Stage Biotech Companies With Strong Preclinical Data</news:title><news:keywords>technology, health, business, entrepreneurship, finance, investing</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/04/14/hot-investor-mandate-us-china-cross-border-firm-invests-in-early-stage-life-science-companies-with-compelling-early-clinical-data/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-14T11:19:00+00:00</news:publication_date><news:title>Hot Investor Mandate: US-China Cross-Border Firm Invests in Early-Stage Life Science Companies With Compelling Early Clinical Data</news:title><news:keywords>technology, health, business, entrepreneurship, finance, investing</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/04/14/hot-investor-mandate-global-vc-firm-with-asia-headquarters-seeks-therapeutics-medical-devices-ai-driven-and-enabling-technologies/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-14T11:19:00+00:00</news:publication_date><news:title>Hot Investor Mandate: Global VC Firm With Asia Headquarters Seeks Therapeutics, Medical Devices, AI-Driven and Enabling Technologies</news:title><news:keywords>technology, health, business, entrepreneurship, finance, investing</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/04/14/hot-investor-mandate-non-profit-organization-invests-in-therapeutics-and-medtech-companies-in-rare-diseases-and-pediatric-innovations/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-14T11:19:00+00:00</news:publication_date><news:title>Hot Investor Mandate: Non-Profit Organization Invests in Therapeutics and Medtech Companies in Rare Diseases and Pediatric Innovations</news:title><news:keywords>technology, health, business, entrepreneurship, finance, investing</news:keywords></news:news></url></urlset>